$477.72
(0.87x)
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Genmab A/S vs Roivant Sciences Ltd.: key figures
 Genmab A/S GMAB |
 Roivant Sciences Ltd. ROIV |
|
|---|---|---|
| Rank | #716 | #821 |
| Price | $549.56 | $40.67 |
| Market cap | $33.79B | $29.38B |
| Shares Outstanding | 61.49M | 722.32M |
| Change (1 day) | +4.48% | +4.60% |
| Change (1 year) | +84.59% | +94.59% |
The other way round: ROIV with the market cap of GMAB
$46.79 (1.15x)
If Roivant Sciences Ltd. (ROIV) had the market cap of Genmab A/S (GMAB), one ROIV would cost $46.79, 1.15 times today's price of $40.67.
Price of ROIV with the Market Cap of GMABPrice of GMAB with the Market Cap of ROIV: the last 12 months
The price of one GMAB if Genmab A/S had the market cap of Roivant Sciences Ltd., at the end of each month. Highest: $477.72 (Nov 2026). Lowest: $230.05 (Nov 2025).
- $230.05 Nov 2025
- $239.12 Dec 2025
- $239.00 Jan 2026
- $327.29 Feb 2026
- $313.26 Mar 2026
- $322.65 Apr 2026
- $343.04 May 2026
- $404.81 Jun 2026
- $396.93 Jul 2026
- $433.58 Oct 2026
- $477.72 Nov 2026
Questions about Genmab A/S and Roivant Sciences Ltd.
What would the price of Genmab A/S be with the market cap of Roivant Sciences Ltd.?
If Genmab A/S (GMAB) had the market cap of Roivant Sciences Ltd. (ROIV), one GMAB would cost $477.72, 13.07% less than today's price of $549.56.
How much bigger is Genmab A/S than Roivant Sciences Ltd.?
The market cap of Genmab A/S ($33.79B) is 1.15 times that of Roivant Sciences Ltd. ($29.38B). In Nov 2025 the gap was 1.38 times.
What would the price of Roivant Sciences Ltd. be with the market cap of Genmab A/S?
If Roivant Sciences Ltd. (ROIV) had the market cap of Genmab A/S (GMAB), one ROIV would cost $46.79, 1.15 times today's price of $40.67.
How is this price calculated?
The market cap of Roivant Sciences Ltd. ($29.38B) is divided by the number of GMAB in circulation (61.49M). Market cap is the price multiplied by the number of coins or shares in circulation.
